PRUITT MICHAEL D (CEO, Chairman) purchased 7.2% of their position (1.10K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $1.1K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/4/2019ACC: 0001493152-19-008644
DirectorOfficer· CEO, Chairman
Since Aug 2018
+1.10K
Net shares
Net buyer
$1.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1.10K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+100.00
Price / share
$1.05
Trade value
$105.00
% of position
3.2%
6/4/2019
3.15K→3.25K
Common Stock
Indirect
Shares
+1K
Price / share
$1.00
Trade value
$1K
% of position
6.5%
6/4/2019
15.46K→16.46K
Total
Net shares
+1.10K
Net value
$1.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/4/2019 | P · Purchase | +100.00 | $1.05 | $105.00 | 3.2% | 3.15K | 3.25K |
| Common Stock Indirect | 6/4/2019 | P · Purchase | +1K | $1.00 | $1K | 6.5% | 15.46K | 16.46K |
| Total | +1.10K | $1.10K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned17.26K
Series 1 Preferred Stock
IndirectShares owned330.00
Total
17.26K direct·330.00 indirect17.59K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 17.26K | Direct |
| Series 1 Preferred Stock | 330.00 | Indirect |
| Total | 17.59K | 17.26K direct·330.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported